Charles M. Shapiro

2.0k total citations · 1 hit paper
36 papers, 1.5k citations indexed

About

Charles M. Shapiro is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charles M. Shapiro has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charles M. Shapiro's work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Charles M. Shapiro is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Charles M. Shapiro collaborates with scholars based in United States and Pakistan. Charles M. Shapiro's co-authors include Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, Donald A. Berry, Hyman B. Muss, Larry Norton, Mark Kozloff, David J. Sugarbaker, Barbara L. Smith and Kevin S. Hughes and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Charles M. Shapiro

36 papers receiving 1.4k citations

Hit Papers

Lumpectomy plus Tamoxifen with or without Irradiation in ... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles M. Shapiro United States 17 762 710 420 263 226 36 1.5k
Ian H. Plenderleith Canada 9 1.1k 1.5× 562 0.8× 572 1.4× 201 0.8× 594 2.6× 13 1.6k
G. Le Bouëdec France 19 699 0.9× 570 0.8× 435 1.0× 169 0.6× 435 1.9× 90 1.7k
A.Y. Rostom United Kingdom 22 296 0.4× 578 0.8× 242 0.6× 367 1.4× 375 1.7× 44 1.3k
Nelson H. Slack United States 19 723 0.9× 736 1.0× 364 0.9× 723 2.7× 433 1.9× 36 2.0k
Roger E. Moe United States 23 1.4k 1.9× 1.1k 1.5× 1.0k 2.4× 231 0.9× 611 2.7× 39 2.4k
Guy F. Robbins United States 25 1.3k 1.8× 885 1.2× 1.0k 2.5× 230 0.9× 381 1.7× 45 2.2k
Giuseppe Canavese Italy 26 1.0k 1.3× 650 0.9× 787 1.9× 212 0.8× 612 2.7× 76 1.8k
F. Rochard France 17 1.4k 1.8× 736 1.0× 953 2.3× 417 1.6× 581 2.6× 29 2.2k
J. Frank Wilson United States 23 584 0.8× 519 0.7× 271 0.6× 404 1.5× 352 1.6× 81 1.6k
V. Izraël France 16 311 0.4× 946 1.3× 298 0.7× 325 1.2× 259 1.1× 37 1.4k

Countries citing papers authored by Charles M. Shapiro

Since Specialization
Citations

This map shows the geographic impact of Charles M. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Shapiro more than expected).

Fields of papers citing papers by Charles M. Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Shapiro. The network helps show where Charles M. Shapiro may publish in the future.

Co-authorship network of co-authors of Charles M. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Shapiro. A scholar is included among the top collaborators of Charles M. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Shapiro. Charles M. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Kevin S., Lauren A. Schnaper, Donald A. Berry, et al.. (2004). Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer. New England Journal of Medicine. 351(10). 971–977. 733 indexed citations breakdown →
2.
Walk, David, et al.. (1998). Mononeuropathy multiplex due to infiltration of lymphoma in hematologic remission. Muscle & Nerve. 21(6). 823–826. 13 indexed citations
3.
Shapiro, Charles M. & David Walk. (1996). Aplastic anemia associated with ticlopidine. Neurology. 47(1). 300–300. 11 indexed citations
4.
Sibley, Gregory S., Arno J. Mundt, Charles M. Shapiro, et al.. (1995). The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 33(5). 1001–1007. 50 indexed citations
5.
Shapiro, Charles M., et al.. (1993). Zinc abuse and sideroblastic anemia. American Journal of Hematology. 42(2). 227–228. 7 indexed citations
6.
Shapiro, Charles M., Enrique Beckmann, Neal P. Christiansen, et al.. (1987). Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies. The American Journal of the Medical Sciences. 293(6). 366–370. 8 indexed citations
7.
Shapiro, Charles M., et al.. (1986). Muir‐torre syndrome. Journal of Surgical Oncology. 31(3). 160–162. 11 indexed citations
8.
Bennett, Charles L., et al.. (1986). Staging and therapy of orbital lymphomas. Cancer. 57(6). 1204–1208. 26 indexed citations
9.
Shapiro, Charles M., et al.. (1984). Malignant feminizing leydig cell tumor. Journal of Surgical Oncology. 27(2). 73–75. 8 indexed citations
10.
Bitran, Jacob D., et al.. (1983). Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy. Cancer. 51(3). 381–384. 21 indexed citations
11.
Shapiro, Charles M., Jacob D. Bitran, Richard K. Desser, et al.. (1982). Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast. Journal of Surgical Oncology. 19(2). 119–121. 23 indexed citations
12.
Walsh, Thomas J., et al.. (1982). Metastatic Fungal Chorioretinitis Developing During Trichosporon Sepsis. Ophthalmology. 89(2). 152–156. 17 indexed citations
13.
Yung, Cheuk W., et al.. (1981). Disseminated trichosporon beigelii (cutaneum). Cancer. 48(9). 2107–2111. 53 indexed citations
14.
Fretzin, David F., et al.. (1980). Bronchial Carcinoid Metastatic to Skin. Journal of Cutaneous Pathology. 7(1). 43–49. 19 indexed citations
15.
Jd, Bitran, et al.. (1980). Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).. PubMed. 63(11-12). 2049–51. 61 indexed citations
16.
Bitran, Jacob D., et al.. (1976). Survival of patients with lung cancer treated with vincristine and actinomycin D.An unsuccessful trial. Cancer. 37(4). 1669–1672. 1 indexed citations
17.
Shapiro, Charles M.. (1974). Antibody Response to Cannabis. JAMA. 230(1). 81–81. 5 indexed citations
18.
Shapiro, Charles M., et al.. (1969). Allopurinol therapy for renal uric acid calculi.. PubMed. 210(11). 2093–4. 3 indexed citations
19.
Shapiro, Charles M., et al.. (1958). Comparative clinical study of Coumadin Sodium and Dicumarol in patients with thromboembolic diseases. American Heart Journal. 55(1). 66–72. 6 indexed citations
20.
Shapiro, Charles M., et al.. (1957). Hereditary spherocytosis in the neonatal period. The Journal of Pediatrics. 50(3). 308–314. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026